About WeGene
WeGene is a company based in Shenzhen (China) founded in 2014.. WeGene operates in a competitive market with competitors including CircleDNA, 23Mofang, GeseDNA, Aijiyin and 1JKT, among others.
- Headquarter Shenzhen, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
K2
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of WeGene
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series B - WeGene | Valuation |
investors |
|
| Aug, 2015 | Amount | Seed - WeGene | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in WeGene
WeGene has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include K2, Huada Gene and Ameba Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and growth stage tech-focused VC firm investing primarily in China
|
Founded Year | Domain | Location | |
|
Genomics research and sequencing services are provided in China.
|
Founded Year | Domain | Location | |
|
Business process management platform provider
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by WeGene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - WeGene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wegene Comparisons
Competitors of WeGene
WeGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CircleDNA, 23Mofang, GeseDNA, Aijiyin and 1JKT, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Internet-first platform for genetic diagnostics is provided.
|
|
| domain | founded_year | HQ Location |
Provides genetic testing services to help prevent potential problems and early intervention.
|
|
| domain | founded_year | HQ Location |
Gene detection tools and DNA interpretation services are provided.
|
|
| domain | founded_year | HQ Location |
Genetic testing solutions are offered via an online platform.
|
|
| domain | founded_year | HQ Location |
Online platform offering appointment booking services for genetic tests
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wegene
Frequently Asked Questions about WeGene
When was WeGene founded?
WeGene was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is WeGene located?
WeGene is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
What does WeGene do?
WeGene was founded in 2014 in Shenzhen, China, within the genetic testing sector. Saliva-based tests are utilized to identify sources of health risks, including hereditary and complex diseases, as well as drug reactions. Characteristics are analyzed to support avoidance of such conditions. The service is priced at 999 yuan, with funding raised from K2 Ventures. Operations focus on direct-to-consumer genetic analysis.
Who are the top competitors of WeGene?
Who are WeGene's investors?
WeGene has 3 investors. Key investors include K2, Huada Gene, and Ameba Capital.